SAPHNELO

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: ad84df800dc83fd4
Drug Approval Canada Name: SAPHNELO
Product Name: SAPHNELO
Status: Marketed
Status Date: 2022-03-01
Original Market Date: 2022-03-01
Din: 02522845
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 90:24.28
Atc Original: L04AG11 ANIFROLUMAB
Atc Name: l 04 ag 11
Aig Number: 0163278001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

ANIFROLUMAB

150 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad84df800dc83fd4

Type

Standard